In his second year of medical school at The University of Texas (UT) Health Science Center at San Antonio, Flitton is ...

A new study published in Experimental Eye Research reported that the preclinical results achieved with SPG302 (Spinogenix, ...

Veradermics raised $150 million to advance VDPHL01, an oral minoxidil treatment for hair regrowth, through Phase III trials ...

Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical ...

For children born with severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID), an investigational ...

The respiratory medical community is moving toward shared decision-making in self-managing chronic respiratory disease, but ...

A crisis of access demands we embrace faster, proven pathways to create the clinicians Canadians desperately need.

CAMBRIDGE, Mass., Oct. 16, 2025 /PRNewswire/ -- Nanopath, a point-of-care diagnostics company enabling high-quality molecular testing in minutes, today announced the addition of five experts to its ...

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to ...

The government should focus on keeping up the funding for HIV to continue to innovate in this space, potentially eliminating ...